Related Experiment Videos
Antibiotics versus placebo for acute bacterial conjunctivitis
1University of Edinburgh, Division of Community Health Sciences: GP Section, 20 West Richmond Street, Edinburgh, UK, EH8 9DX. Aziz.Sheikh@ed.ac.uk
The Cochrane Database of Systematic Reviews
|April 21, 2006
Summary
Antibiotic therapy for acute bacterial conjunctivitis significantly improves clinical and microbiological remission rates, though many cases resolve spontaneously. This review assessed the benefits and harms of antibiotic use in managing this common eye infection.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Evidence-Based Medicine
Background:
- Acute bacterial conjunctivitis is a common condition with ongoing debate regarding the clinical efficacy of antibiotic treatment.
- Concerns exist about the necessity and benefit of antibiotic therapy for acute bacterial conjunctivitis.
Purpose of the Study:
- To systematically review and assess the benefits and harms of antibiotic therapy in the management of acute bacterial conjunctivitis.
Main Methods:
- A comprehensive search of multiple databases (CENTRAL, MEDLINE, EMBASE, PubMed) was conducted.
- Included were double-masked randomized controlled trials comparing antibiotic treatments (topical, systemic, combination) with placebo.
- Data extraction and accuracy checking were performed by two authors.
Main Results:
- Five trials involving 1034 participants were analyzed; results were heterogeneous.
- Topical antibiotics showed benefit in early clinical and microbiological remission (days 2-5) and this benefit persisted, albeit reduced, later (days 6-10).
- Most cases resolved spontaneously; no serious sight-threatening complications were reported.
Conclusions:
- Acute bacterial conjunctivitis is often self-limiting, but antibiotic use is linked to improved clinical and microbiological remission rates.
- The findings support the use of antibiotics for acute bacterial conjunctivitis, balancing potential benefits against the self-limiting nature of the condition.